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Purpose/Objective: Interfractional changes in target and 
organ position and shape during external beam radiotherapy 
(EBRT) of cervical cancer patients may be of significant 
magnitude (Figure 1). To compensate for motion, application 
of relatively large CTV-PTV margins is often applied, which 
can reduce the clinical advantages of e.g. IMRT. The study 
aimed to evaluate the patterns of target and organ motion 
during EBRT and to evaluate the impact on dose delivery with 
specific focus on dose to the uterine body.  
Materials and Methods: Ten patients with locally advanced 
cervical cancer treated with chemoradiation and 
brachytherapy were analysed. EBRT was delivered as 45-50 
Gy in 25-30 fractions using daily online cone beam computed 
tomography (CBCT) for patient set up. Treatment was in 
supine position, and a drinking protocol was applied to obtain 
a full bladder. The clinical target volume (CTV) encompassed 
the gross tumour volume (GTV), cervix, parametrium, uterus, 
upper vagina and the nodal CTV. Cervix/uterus as well as 
bladder and rectum were delineated on each CBCT, and 
transferred to the planning CT. The impact of a reduced 
margin strategy of 0.5 cm CTV-PTV for the uninvolved uterus 
was compared to our standard of 1.5 cm. Uterus DVH 
parameters were extracted for each fraction and D98 was 
summed for both scenarios with evaluation of the percentage 
of fractions where D98 was less than 95% and 90% of 
prescribed dose. Bladder volume was assessed for each 
fraction to analyse for time trends and to evaluate a 
correlation between uterine coverage and bladder volume. 
Results: In 6/10 patients the uterus D98 was at least 95% of 
prescribed dose in at least 92% of all fractions for the 
reduced margin strategy. In the remaining 4 patients the D98 
was less than 95% in at least 5 fractions for the reduced 
margin strategy. In 2/4 patients the lack of coverage was 
correlated with the bladder filling which was significantly 
different from the bladder volume in the treatment planning 
scan (p=0.001, p=0.02). In 2/4 patients there was no 
correlation between bladder volume and lack of coverage 
(p=0.33, p=0.19). For all patients and for both margin 
strategies, the fractional dose summation for uterus D98 was 
>90% which corresponded to at least 40.5 Gy (table 1). 
 
Conclusions: Treatment plans with standard margin and 
reduced margin were robust to organ motion in terms of 
fractional dose summation. The uterus D98 was at least 90% 
of prescribed dose for all patients. Taking into account that 
brachytherapy delivers additional 5-10 Gy to the uninvolved 
uterine body, the summed uterine dose will be well above 
45Gy, which is often considered appropriate for targeting 
tissue at risk of microscopic spread. Dose coverage was partly 
but not consistently correlated to variation in bladder 
volume. This may indicate that an adaptive radiotherapy 
approach based on a library plan selection strategy should 
include evaluation of bladder volume and location of uterine 
body. 
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Purpose/Objective: Cherenkov emission from water tank is 
possible at 20 frames per second acquisition, and so this 
allows direct high resolution visualization of the delivery of 
IMRT and VMAT plans for the first time ever. This study 
focuses on the temporal and spatial capabilities of the first 
2+D, and 3D Cherenkov water imaging systems.  
Materials and Methods: Cherenkov emission was imaged from 
a standard water tank, with 1g/L quinine sulphate in 
solution. The emission was detected using a time-gated ICCD 
camera synchronized to the LINAC pulses at 200Hz. Images 
were collected at 20Hz with room lights on, using background 
acquisition and subtraction. 2+D imaging of TG-119 plans was 
done with imaging treatments from one perspective. 3D 
imaging was done for a static beam by rotating the water 
tank and camera through 360 degrees during imaging.  
Results: 2+D imaging of delivery can be achieved with 
extremely high resolution (300 microns) using the appropriate 
lens and ICCD, and the ability to capture the volumetric 
temporal kinetics of delivery is unique to this type of imaging 
system. The agreement between Cerenkov image and dose 
map from the treatment planning system was greater than 
96% from gamma analysis using a 3%/3mm criteria. 3D 
imaging of individual beams illustrates how high resolution 
features of the MLC can be captured, and even leakage 
radiation through the closed MLCs and the end leakage can 
be visualized with high SNR.  
Conclusions: The niche area of Cherenkov imaging of 
IRMT/VMAT delivery in water tanks can allow for high 
resolution fast data acquisition. The agreement between 
Cherenkov emission and dose is very good, indicating it 
should be acceptable as a surrogate measure of dose under 
certain conditions.  
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Purpose/Objective: Tumour delineation is a challenging and 
time-consuming part of radiotherapy planning. The task has 
become more complex with the increased popularity of 
multi-sequence and multimodal imaging. The purpose of this 
study was to investigate how we could combine images from 
different MR sequences and use them for automatic 
segmentation of cervical cancer tumours. 
Materials and Methods: Seventy-eight patients with 
advanced cervical cancer where imaged using three different 
MRI sequences: T2-weighted MRI, T1-weighted MRI and 
dynamic contrast enhanced (DCE) MRI. These images were 
used separately or in combination as input to a Fisher’s 
Linear Discriminant Analysis classifier. We trained the 
classifier to identify each voxel as either tumour or non-
tumour, using the radiologist’s delineations as ground truth. 
The segmentation results provided probability maps, giving 
the probability of each voxel belonging to the tumour. We 
used leave-one-patient-out cross-validation to assess the 
classifier’s performance.  
Results: The best segmentation model resulted in a Dice 
similarity coefficient of 0.37 and a Kappa value of 0.33 after 
cross-validation. This result is similar to the results from a 
previous study of agreement between radiologists. The DCE-
MRI time series significantly improved tumour segmentation. 
The T1-weighted images gave a smaller, but also significant, 
increase in performance. Even though the radiologist used 
the T2-weighted images for delineation, these images did not 
improve the performance of the automatic segmentation 
model.  
Conclusions: Our results suggest that DCE-MRI and T1-
weighted MRI contain information relevant for automatic 
cervical tumour segmentation. The proposed method can 
easily be extended to include other image types, for example 
diffusion weighted MRI. 
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